title: [Efficacy of prolonged-release somatostatin analog monotherapy in metastatic endocrine tumors].
authors.forename: J-M
authors.initials: JM
authors.lastname: Kanyinda-K
authors.forename: E
authors.initials: E
authors.lastname: Samalin
authors.forename: H
authors.initials: H
authors.lastname: Sebah
authors.forename: B
authors.initials: B
authors.lastname: Gallix
authors.forename: M
authors.initials: M
authors.lastname: Ychou
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008297:Male; D018358:Neuroendocrine Tumors / Q000188:drug therapy* / Q000556:secondary*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin